Self-monitoring blood glucose devices: By Product (Test Strips, Lancets, Blood Glucose Meters), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By End User (Hospitals, Home Settings, Diagnostic Centers), And Region – Global Analysis of Market Size, Share & Trends For 2019–2021 And Forecasts To 2031
Self-monitoring blood glucose devices: By Product (Test Strips, Lancets, Blood Glucose Meters), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By End User (Hospitals, Home Settings, Diagnostic Centers), And Region – Global Analysis of Market Size, Share & Trends For 2019–2021 And Forecasts To 2031
PRODUCT OVERVIEW
Self-monitoring blood glucose devices are portable device that are used in monitoring the blood glucose level. People suffering with diabetes can check their blood sugar before eating and after eating with accuracy of measured results. It helps in maintaining the record and monitor the effect of treatment on sugar level in blood. The patients facing fluctuation in glucose level monitor their blood glucose levels routinely to put right doses of insulin, in which self-monitoring blood glucose devices are very helpful.
MARKET HIGHLIGHTS
Global Self-monitoring blood glucose devices market is expected to project a notable CAGR of xx% in 2031.
Global Self-monitoring blood glucose devices to surpass USD xx billion by 2031 from USD xx billion in 2021 at a CAGR of xx% in the coming years, i.e., 2021-31. The diabetic patient population is increasing globally due to fast change in lifestyle with fewer physical activities is important factor expected to fuel the growth of the glucose monitoring devices market. Furthermore, advancement of technology and the growing awareness regarding diabetes are also major reasons propelling the growth of global self-monitoring blood glucose market over the forecast period.
GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES: SEGMENTS
Test Strips segment to grow with the highest CAGR during 2021-31
Global Self-monitoring blood glucose devices market is classified on the basis of Product into Test Strips, Lancets, Blood Glucose Meters. Test strips segment held the largest market share and grasp its dominance over the forecast years. Low-cost pricing of test strips as compared to glucose meters and easy availability of test strips are significant factors boosting the growth of test strips segment in self-monitoring blood glucose market. The growth of the market is expected to boost with increasing global diabetic population.
Type 2 Diabetes segment to grow with the highest CAGR during 2021-31
Based on application, global Self-monitoring blood glucose devices Market is fragmented into Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes. By application, self-monitoring blood glucose devices market dominated by type 2 diabetes segment. With the growing geriatric population, rise in ascendancy of obesity, and sluggish lifestyle are significant factors expected to fuel the growth of type 2 diabetes segment during the forecast period.
MARKET DYNAMICS
Drivers
Rising prevalence of diabetes worldwide
Government initiatives and improvement in R&D
Restraint
Lack of awareness
GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES:
Key Players
SELF-MONITORING BLOOD GLUCOSE DEVICES SEGMENTS:
PRODUCT OVERVIEW
Self-monitoring blood glucose devices are portable device that are used in monitoring the blood glucose level. People suffering with diabetes can check their blood sugar before eating and after eating with accuracy of measured results. It helps in maintaining the record and monitor the effect of treatment on sugar level in blood. The patients facing fluctuation in glucose level monitor their blood glucose levels routinely to put right doses of insulin, in which self-monitoring blood glucose devices are very helpful.
MARKET HIGHLIGHTS
Global Self-monitoring blood glucose devices market is expected to project a notable CAGR of xx% in 2031.
Global Self-monitoring blood glucose devices to surpass USD xx billion by 2031 from USD xx billion in 2021 at a CAGR of xx% in the coming years, i.e., 2021-31. The diabetic patient population is increasing globally due to fast change in lifestyle with fewer physical activities is important factor expected to fuel the growth of the glucose monitoring devices market. Furthermore, advancement of technology and the growing awareness regarding diabetes are also major reasons propelling the growth of global self-monitoring blood glucose market over the forecast period.
GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES: SEGMENTS
Test Strips segment to grow with the highest CAGR during 2021-31
Global Self-monitoring blood glucose devices market is classified on the basis of Product into Test Strips, Lancets, Blood Glucose Meters. Test strips segment held the largest market share and grasp its dominance over the forecast years. Low-cost pricing of test strips as compared to glucose meters and easy availability of test strips are significant factors boosting the growth of test strips segment in self-monitoring blood glucose market. The growth of the market is expected to boost with increasing global diabetic population.
Type 2 Diabetes segment to grow with the highest CAGR during 2021-31
Based on application, global Self-monitoring blood glucose devices Market is fragmented into Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes. By application, self-monitoring blood glucose devices market dominated by type 2 diabetes segment. With the growing geriatric population, rise in ascendancy of obesity, and sluggish lifestyle are significant factors expected to fuel the growth of type 2 diabetes segment during the forecast period.
MARKET DYNAMICS
Drivers
Rising prevalence of diabetes worldwide
Government initiatives and improvement in R&D
Restraint
Lack of awareness
GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES:
Key Players
- F. Hoffmann-La Roche Ltd
- Dexcom Inc
- Bayer AG
- Medtronic Public Limited
- Abbott Laboratories
- B. Braun Melsungen AG
- Arkray, Inc.
- Trividia Health Inc.
- Bionime Corporation
- Life Scan Inc.
- Other Prominent Players
SELF-MONITORING BLOOD GLUCOSE DEVICES SEGMENTS:
- By Product
- Test Strips
- Lancets
- Blood Glucose Meters
- By Application
- Type 1 Diabetes
- Type 2 Diabetes
- Gestational Diabetes
- By End User
- Hospitals,
- Home Settings,
- Diagnostic Centers
- Self-monitoring blood glucose devices Dynamics
- Self-monitoring blood glucose devices Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies Involved in the Market
- Value Chain of the Market
- Market Drivers and Restraints
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 3-month post-sales analyst support.
1. EXECUTIVE SUMMARY
2 GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3 RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4 AVERAGE PRICING ANALYSIS
5 MACRO-ECONOMIC INDICATORS
6 MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7 CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8 RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9 RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10 GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11 GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET
11.1. Market Size & forecast, 2020A-2031F
11.1.1. By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
11.1.2. By Volume (Million Units) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12 GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET: MARKET SEGMENTATION
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2. By Product: Market Share (2020-2031F)
12.2.1. Test Strips, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.2. Lancets, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.3. Blood Glucose Meters, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3. By Application: Market Share (2020-2031F)
12.3.1. Type 1 Diabetes, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.2. Type 2 Diabetes, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.3. Gestational Diabetes, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4. By End User: Market Share (2020-2031F)
12.4.1. Hospitals, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.2. Home Settings, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.3. Diagnostic Centers, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
13 COMPANY PROFILE
13.1. F. Hoffmann-La Roche Ltd
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Dexcom Inc
13.3. Bayer AG
13.4. Medtronic Public Limited
13.5. Abbott Laboratories
13.6. B. Braun Melsungen AG
13.7. Arkray, Inc.
13.8. Trividia Health Inc.
13.9. Bionime Corporation
13.10. Life Scan Inc.
13.11. Other Prominent Players
14 CONSULTANT RECOMMENDATION
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
2 GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3 RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4 AVERAGE PRICING ANALYSIS
5 MACRO-ECONOMIC INDICATORS
6 MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7 CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8 RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9 RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10 GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11 GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET
11.1. Market Size & forecast, 2020A-2031F
11.1.1. By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
11.1.2. By Volume (Million Units) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12 GLOBAL SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET: MARKET SEGMENTATION
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2. By Product: Market Share (2020-2031F)
12.2.1. Test Strips, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.2. Lancets, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.3. Blood Glucose Meters, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3. By Application: Market Share (2020-2031F)
12.3.1. Type 1 Diabetes, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.2. Type 2 Diabetes, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.3. Gestational Diabetes, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4. By End User: Market Share (2020-2031F)
12.4.1. Hospitals, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.2. Home Settings, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.3. Diagnostic Centers, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
13 COMPANY PROFILE
13.1. F. Hoffmann-La Roche Ltd
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Dexcom Inc
13.3. Bayer AG
13.4. Medtronic Public Limited
13.5. Abbott Laboratories
13.6. B. Braun Melsungen AG
13.7. Arkray, Inc.
13.8. Trividia Health Inc.
13.9. Bionime Corporation
13.10. Life Scan Inc.
13.11. Other Prominent Players
14 CONSULTANT RECOMMENDATION
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
